Extracellular Vesicles: Catching the Light of Intercellular Communication in Fibrotic Liver Diseases

Overview

Journal Theranostics

Date 2022 Oct 24

PMID 36276639

Authors

Yijie Li

Jianzhi Wu

Runping Liu

Yinhao Zhang

Xiaojiaoyang Li

Affiliations

Soon will be listed here.

Abstract

The increasing prevalence of fibrotic liver diseases resulting from different etiologies has become a major global problem for public health. Fibrotic liver diseases represent a redundant accumulation of extracellular matrix, dysregulation of immune homeostasis and angiogenesis, which eventually contribute to the progression of cirrhosis and liver malignancies. The concerted actions among liver cells including hepatocytes, hepatic stellate cells, kupffer cells, liver sinusoidal endothelial cells and other immune cells are essential for the outcome of liver fibrosis. Recently, a growing body of literature has highlighted that extracellular vesicles (EVs) are critical mediators of intercellular communication among different liver cells either in local or distant microenvironments, coordinating a variety of systemic pathological and physiological processes. Despite the increasing interests in this field, there are still relatively few studies to classify the contents and functions of EVs in intercellular transmission during hepatic fibrogenesis. This review aims to summarize the latest findings with regards to the cargo loading, release, and uptake of EVs in different liver cells and clarify the significant roles of EVs played in fibrotic liver diseases.

Citing Articles

The Role of Extracellular Vesicles in Liver Fibrosis: Friends or Foes?.

Tao X, Chen C, Liu M Biomedicines. 2025; 12(12.

PMID: 39767572 PMC: 11726879. DOI: 10.3390/biomedicines12122665.

Extracellular Vesicles in Viral Liver Diseases.

Kouroumalis E, Tsomidis I, Voumvouraki A Viruses. 2024; 16(11).

PMID: 39599900 PMC: 11598962. DOI: 10.3390/v16111785.

Promising nanotherapeutics of stem cell extracellular vesicles in liver regeneration.

Guo N, Wang Y, Wen Z, Fan X Regen Ther. 2024; 26:1037-1047.

PMID: 39569342 PMC: 11576938. DOI: 10.1016/j.reth.2024.09.016.

Liver cirrhosis: molecular mechanisms and therapeutic interventions.

Dong Z, Wang Y, Jin W MedComm (2020). 2024; 5(10):e721.

PMID: 39290252 PMC: 11406049. DOI: 10.1002/mco2.721.

From biogenesis to aptasensors: advancements in analysis for tumor-derived extracellular vesicles research.

Yang G, Li Z, Usman R, Liu Y, Li S, Chen Z Theranostics. 2024; 14(10):4161-4183.

PMID: 38994022 PMC: 11234286. DOI: 10.7150/thno.95885.

References

Luo X, Luo S, Xu Z, Zhou C, Li Z, Zhou X . Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World J Gastroenterol. 2021; 27(14):1419-1434. PMC: 8047533. DOI: 10.3748/wjg.v27.i14.1419. View

Wu X, Shu L, Zhang Z, Li J, Zong J, Cheong L . Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. Adv Sci (Weinh). 2021; 8(11):e2003721. PMC: 8188197. DOI: 10.1002/advs.202003721. View

Montaldo C, Terri M, Riccioni V, Battistelli C, Bordoni V, DOffizi G . Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response. J Hepatol. 2021; 75(6):1301-1311. DOI: 10.1016/j.jhep.2021.07.003. View

Lee Y, Kim S, Ko E, Lee J, Yi H, Yoo Y . Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017; 7(1):3710. PMC: 5473841. DOI: 10.1038/s41598-017-03389-2. View

Zhou Y, Ren H, Dai B, Li J, Shang L, Huang J . Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res. 2018; 37(1):324. PMC: 6307162. DOI: 10.1186/s13046-018-0965-2. View

Li X, Liu R, Wang Y, Zhu W, Zhao D, Wang X . Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions. Cells. 2020; 9(1). PMC: 7016679. DOI: 10.3390/cells9010190. View

Giugliano S, Kriss M, Golden-Mason L, Dobrinskikh E, Stone A, Soto-Gutierrez A . Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology. 2014; 148(2):392-402.e13. PMC: 4765499. DOI: 10.1053/j.gastro.2014.10.040. View

Maas S, Breakefield X, Weaver A . Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol. 2016; 27(3):172-188. PMC: 5318253. DOI: 10.1016/j.tcb.2016.11.003. View

El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View

10.

Todkar K, Chikhi L, Desjardins V, El-Mortada F, Pepin G, Germain M . Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. Nat Commun. 2021; 12(1):1971. PMC: 8009912. DOI: 10.1038/s41467-021-21984-w. View

11.

Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R . The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep. 2016; 17(3):799-808. DOI: 10.1016/j.celrep.2016.09.031. View

12.

Li Y, Liu R, Ding M, Zheng Q, Wu J, Xue X . Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles. Acta Pharmacol Sin. 2022; 43(8):2026-2041. PMC: 9343419. DOI: 10.1038/s41401-021-00843-w. View

13.

Hirsova P, Ibrahim S, Krishnan A, Verma V, Bronk S, Werneburg N . Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. Gastroenterology. 2016; 150(4):956-67. PMC: 4808464. DOI: 10.1053/j.gastro.2015.12.037. View

14.

Khomich O, Ivanov A, Bartosch B . Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells. 2019; 9(1). PMC: 7016711. DOI: 10.3390/cells9010024. View

15.

Chen L, Chen R, Kemper S, Cong M, You H, Brigstock D . Therapeutic effects of serum extracellular vesicles in liver fibrosis. J Extracell Vesicles. 2018; 7(1):1461505. PMC: 5912192. DOI: 10.1080/20013078.2018.1461505. View

16.

Li X, Liu R, Huang Z, Gurley E, Wang X, Wang J . Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology. 2018; 68(2):599-615. PMC: 6085159. DOI: 10.1002/hep.29838. View

17.

Wang L, Wang Y, Quan J . Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis. Hum Cell. 2020; 33(3):582-589. DOI: 10.1007/s13577-020-00371-5. View

18.

Povero D, Panera N, Eguchi A, Johnson C, Papouchado B, Horcel L . Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ. Cell Mol Gastroenterol Hepatol. 2016; 1(6):646-663.e4. PMC: 4714359. DOI: 10.1016/j.jcmgh.2015.07.007. View

19.

Liao C, Song M, Gao Y, Mauer A, Revzin A, Malhi H . Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis. Front Immunol. 2019; 9:2980. PMC: 6305739. DOI: 10.3389/fimmu.2018.02980. View

20.

Li Y, Zhang X, Zheng Q, Zhang Y, Ma Y, Zhu C . YAP1 Inhibition in HUVECs Is Associated with Released Exosomes and Increased Hepatocarcinoma Invasion and Metastasis. Mol Ther Nucleic Acids. 2020; 21:86-97. PMC: 7281784. DOI: 10.1016/j.omtn.2020.05.021. View